Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases

BACKGROUND: The COVID-19 pandemic has brought increased focus on hydroxychloroquine (HCQ), as doctors, the medical community, and policymakers around the world attempt to understand how the risks of HCQ weigh against unknown benefits. We aim to evaluate the effects of HCQ on cardiac conduction, thus...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yanting, Xu, Jianteng, Xie, Anni, Liu, Sijia, Wang, Xiaojian, Zhu, Runzhang, Wang, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089424/
https://www.ncbi.nlm.nih.gov/pubmed/34192120
http://dx.doi.org/10.1159/000515278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089424/
https://www.ncbi.nlm.nih.gov/pubmed/34192120
http://dx.doi.org/10.1159/000515278

Ejemplares similares